Understanding the Cellular and Molecular Mechanisms of Gastroparesis in Adults and Children (R01 Clinical Trial Not Allowed)

Funding Agency:
National Institutes of Health

Since its establishment in 2006, the Gastroparesis Clinical Research Consortium (GpCRC), a multi-center coalition created and funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) has made major advances to our understanding of the pathophysiology of Gastroparesis (Gp).

Through the establishment of the largest gastroparesis tissue repository in the United States, combined with detailed phenotypic data, the GpCRC is ideally suited to accelerate insights into the underlying cellular and molecular pathophysiology of the gastroparesis with the ultimate goal of developing therapeutic target(s).

This RFA invites investigators from several disciplines, including basic and translational research in areas of neurosciences, immunology, microbiology and physiology, to contribute new insights into the cellular and molecular mechanisms of Gastroparesis.

Only one application per institution is allowed.


  • Duke Internal: Interested applicants from within Duke should contact dukeiln@duke.edu as early as possible.
  • Letter of Intent Due Date(s): February 3, 2021

  • Application Due Date(s): March 3, 2021

RFA-DK-20-030 Expiration Date March 4, 2021

Agency Website



Amount Description

Application budgets are limited to $250,000 in direct costs per year. Application budgets should reflect the actual needs of the proposed project.

The maximum project period is 5 years.

Funding Type





Medical - Basic Science
Medical - Translational

External Deadline

March 3, 2021